Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 7 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Q3 2022 vs. Q2 2022
How the institutions holding Roivant Sciences Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 78 | +8 |
| Shares | 360.5M | 15.7K | 370.5M | +10.0M (+2.8%) |
| Value | $1.47B | $64.0K | $1.19B | −$274.0M (−18.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Roivant Sciences Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 2,499,335 | $8.05M | 0.12% |
| Edge Wealth Management LLC | 268,032 | $871.0K | 0.19% |
| Marshall Wace, LLP | 143,413 | $461.0K | 0.00% |
| Legal & General Group Plc | 97,917 | $315.0K | 0.00% |
| Millennium Management LLC | 83,688 | $269.0K | 0.00% |
| Ensign Peak Advisors, Inc | 35,600 | $115.0K | 0.00% |
| American Century Companies Inc | 28,352 | $91.0K | 0.00% |
| Bayesian Capital Management, LP | 17,525 | $56.0K | 0.01% |
| BNP Paribas Arbitrage, SA | 15,200 | $48.9K | 0.00% |
| Jane Street Group, LLC | 14,918 | $48.0K | 0.00% |
| Group One Trading, L.P. | 11,100 | $36.0K | 0.00% |
| Daiwa Securities Group Inc. | 10,796 | $35.0K | 0.00% |
| Itau Unibanco Holding S.A. | 3,765 | $12.0K | 0.00% |
| Allworth Financial LP | 551 | $2.00K | 0.00% |
| Signaturefd, LLC | 47 | $0 | 0.00% |
Sold out (7)
Institutions that held Roivant Sciences Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 876,996 | $3.57M |
| Suvretta Capital Management, LLC | 681,528 | $2.77M |
| Brookfield Asset Management Inc. | 149,200 | $607.0K |
| Tang Capital Management LLC | 101,404 | $413.0K |
| Penserra Capital Management LLC | 17,771 | $72.0K |
| Cutler Group LP | 5,800 | $23.0K |
| Cubist Systematic Strategies, LLC | 998 | $4.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Roivant Sciences Ltd. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exos Asset Management LLC | 15,724 | $64.0K |